• Unichem Laboratories gets USFDA nod for drug to treat irregular heartbeat

    • July 23, 2020
    • Posted By : admin
    • 0 Comment
    •   1 views

    Drug firm Unichem Laboratories NSE 2.05 % on Wednesday said it has received approval from the US health regulator for its Amiodarone tablets used to treat irregular heartbeat. The approved product is a generic version of Wyeth Pharmaceuticals Inc’s Cordarone tablets.

    The company has received abbreviated new drug application (ANDA) approval for its Amiodarone tablets, USP, 200 mg from the United States Food and Drug Administration (USFDA), Unichem Labs said in a filing to the BSE.

    Amiodarone tablets are indicated for the treatment of documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated.

  1 views

You Might Also Like

No comments found

LEAVE COMMENT

Archive

Offers
error: Content is protected !!